Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids
about
Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning methodIsolation and characterization of a membrane-attack-complex-inhibiting protein present in human serum and other biological fluidsProtection of human amniotic epithelial cells (HAEC) from complement-mediated lysis: expression on the cells of three complement inhibitory membrane proteinsRelease of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase DStructural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55)Myasthenia gravis: past, present, and futureThe HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55)Fibroblast biology. Development and differentiation of synovial fibroblasts in arthritis.Do antimicrobial peptides and complement collaborate in the intestinal mucosa?Effect of IL-4 on altered expression of complement activation regulators in rat pancreatic cells during severe acute pancreatitisInhibiting complement regulators in cancer immunotherapy with bispecific mAbs.TEX101, a glycoprotein essential for sperm fertility, is required for stable expression of Ly6k on testicular germ cells.Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.Enterovirus 70 binds to different glycoconjugates containing alpha2,3-linked sialic acid on different cell lines.Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells.Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions.Inhibitors of complement activity in human breast-milk: a proposed hypothesis of their physiological significanceThe intrinsic complement regulator decay-accelerating factor modulates the biological response to vascular injuryRole of decay-accelerating factor domains and anchorage in internalization of Dr-fimbriated Escherichia coliStructure-function analysis of decay-accelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulationRole and significance of the complement system in mucosal immunity: particular reference to the human breast milk complement.Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants.Triggering of the dsRNA sensors TLR3, MDA5, and RIG-I induces CD55 expression in synovial fibroblastsSialic acid functions in enterovirus 70 binding and infectionDifferential expression of complement proteins and regulatory decay accelerating factor in relation to differentiation of cultured human colon adenocarcinoma cell lines.Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.The role of complement in tumor growthMolecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisition.Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytesConstitutive expression of murine decay-accelerating factor 1 is controlled by the transcription factor Sp1.Expression and localization of proteins of the complement system in human skin.Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59.Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanismsChronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical diseaseAntigen-presenting cell engineering. The molecular toolboxHuman carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice
P2860
Q24306280-483CD947-AAEB-45D0-8C8B-0643C31A5AE3Q24528248-B55804E2-DF12-4DFA-8DBA-3BC1FDAF8A01Q24541458-F1B9FFFD-EBE7-4F7A-9E81-386B61F5EAAFQ24595979-15CE2529-65DF-4EE3-B435-9F169EDD9F52Q24642928-BE3F7B78-0005-46EF-B5A4-581333790D21Q24678531-BEF1C699-C216-4E1B-A480-7E10DF2F7C03Q24682005-6EFDC636-6F88-451B-94D2-7D618A472ADBQ24792400-3190296A-8A16-444B-822C-26025E8A1535Q26865903-DB59FE9D-FA3A-4530-BB30-EE1D442C8738Q28580630-0658A8E7-F692-46EE-85FA-4D6EFDF920E2Q33228198-63E39532-D3EC-4E40-8B27-1E8F57085BBCQ33289334-6530D3F1-E045-4503-8308-BD2DE5FCE054Q33417246-F8724595-3190-4911-A483-40C8DA05C348Q33755215-94282D36-C375-416C-9F16-4097938C6BAAQ33788674-2E548D66-250C-46EB-AFFE-244BA364C908Q33848157-695D76C7-8D19-46BB-A5C5-F034BBB3240EQ33848520-F81B2046-60F4-45D6-A8F0-BFFCE2F82C8FQ33855076-7A233A2D-2609-4C75-856A-017F97803026Q33990334-CDD50EC7-1620-4E0C-82C7-89CEA182FCD2Q34003569-4A52CDF3-643C-4ED2-B9CC-4607DBFBAA4BQ34127130-92023536-E992-4437-B0C2-7EF7F2569AFFQ34135699-46557154-D6CF-470F-85ED-4287F5FBB4B7Q34264494-14E91489-A4F5-427B-8159-0665CC8568AFQ34270626-61B3EAA6-0302-4415-912F-B8B7D43A4C04Q34355181-4AFC02C9-CBB2-4718-9740-9E553FB95C6DQ34409314-52FFCAEE-5BDC-4592-8ED6-3B0BD7F4B4FCQ34576112-2B8CF87D-2042-4C25-8882-F4015B8768A2Q35231345-7677231C-0EB6-48B0-A125-5D42E1E62EA1Q35439695-85E63ECD-B50C-4D21-B1F8-3FC807005701Q35563204-3335CC1C-C0E9-4000-BDAA-FFEFBBB31EC6Q35575831-ECC1786D-87CB-4B2A-9C09-35E7C87573DAQ35578822-7C178FA3-A59D-40C5-8ED9-5F4C5C3482B0Q35609010-F2A43E36-AFE7-4E42-AF8F-868B636CE72AQ35677703-C073127C-6FB4-4433-BD18-91D3C0A5D7C0Q35691607-EF2A6711-76C4-434C-AFDC-F64BF0E0E926Q35750345-D229B79D-47A8-4199-8E28-326359CD8383Q35764045-E5BBC29F-C24D-4538-AA07-DAC9B8AA6D3DQ35773889-87C216FF-725F-470D-8753-D803BA00A73CQ35782339-7FB1161E-7354-48CE-BB7A-4AF52916C629Q35789124-CB18079B-80B8-4AEF-B91A-C1F30A2604E7
P2860
Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Identification of the compleme ...... dular cells and in body fluids
@ast
Identification of the compleme ...... dular cells and in body fluids
@en
type
label
Identification of the compleme ...... dular cells and in body fluids
@ast
Identification of the compleme ...... dular cells and in body fluids
@en
prefLabel
Identification of the compleme ...... dular cells and in body fluids
@ast
Identification of the compleme ...... dular cells and in body fluids
@en
P2093
P2860
P356
P1476
Identification of the compleme ...... dular cells and in body fluids
@en
P2093
D M Knowles
E I Walter
J L Rutgers
V Nussenzweig
P2860
P304
P356
10.1084/JEM.165.3.848
P407
P577
1987-03-01T00:00:00Z